β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats

Abstract Background Non-alcoholic steatohepatitis (NASH) is a chronic disease characterized by inflammation, steatosis, and liver fibrosis. The liver is particularly affected by alterations in lipid metabolism. Our aim was to evaluate the effect of β-hydroxyphosphocarnitine (β-HPC) on NASH induced i...

Full description

Saved in:
Bibliographic Details
Main Authors: Janet Sánchez-Quevedo (Author), Emmanuel Ocampo-Rodríguez (Author), Elizabeth Alvarez-Ayala (Author), Anahí Rodríguez-López (Author), Miguel Angel Duarte-Vázquez (Author), Jorge Luis Rosado (Author), Lourdes Rodríguez-Fragoso (Author)
Format: Book
Published: BMC, 2022-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items